Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Charles River Labs | Contract Pharma

What are you searching for?

Sign in
Financial News

Financial Report: Charles River Labs

Manufacturing Support segment drives growth in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Charles River Labs
 
4Q Revenues: $353.9 million (+7%)

4Q Earnings: $32.4 million (+17%)

FY Revenues: $1.4 billion (+5%)

FY Earnings: $151.1 million (+18%)

Comments: Revenue for the Research Models and Services segment was $114.7 million in the quarter, down 3%. Discovery and Safety Assessment revenues were $160.5 million, up 7%. Manufacturing Support revenues were $78.6 million, up 26%, reflecting the acquisitions of Celsis and Sunrise Farms, which contributed 14% to revenue growth. Foreign exchange reduced reported revenue growth by 4%.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics